Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Clin Endocrinol (Oxf) ; 17(5): 457-68, 1982 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-6293740

RESUMEN

The case reported is of a 46-year-old woman who had congenital adrenal hyperplasia due to a 21-hydroxylase deficiency, and in whom there was the development of an ACTH secreting pituitary tumour. The patient was untreated with glucocorticoids until the age of 32 years when she presented with infertility. She next presented with amenorrhoea at the age of 44 years when she was found to have an enlarged pituitary fossa. Despite treatment with bromocriptine and adequate doses of dexamethasone, the tumour enlarged and required operative treatment 1 year later. Before and after operation, plasma ACTH levels were between 300 and 400 ng/l, immunocytochemistry showed staining for ACTH and other structurally related pro-opiocortin peptides but for no other hormones, and the tumour secreted large amounts of ACTH in vitro. The report of this case is to our knowledge the first account of a feedback tumour in congenital adrenal hyperplasia and provides yet another reason why patients with this condition should be treated, and good control achieved.


Asunto(s)
Adenoma Basófilo/etiología , Hiperplasia Suprarrenal Congénita/complicaciones , Hormona Adrenocorticotrópica/biosíntesis , Neoplasias Hipofisarias/etiología , Adenoma Basófilo/tratamiento farmacológico , Adenoma Basófilo/metabolismo , Hormona Adrenocorticotrópica/sangre , Bromocriptina/uso terapéutico , Dexametasona/uso terapéutico , Femenino , Humanos , Persona de Mediana Edad , Neoplasias Hipofisarias/tratamiento farmacológico , Neoplasias Hipofisarias/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA